Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the Nephrogenic Diabetes Insipidus Gene Panel test is 21 business days.

What are the prerequisites for the test Nephrogenic Diabetes Insipidus Gene Panel

  • Patient must have symptoms consistent with nephrogenic diabetes insipidus
  • Referral from a healthcare provider
  • Consent form signed by the patient or guardian
  • Insurance information provided

What are the measure values for the test Nephrogenic Diabetes Insipidus Gene Panel

  • AVPR2 Gene: Sequencing analysis
  • AQP2 Gene: Sequencing analysis
  • Genomic Deletion/Duplication Analysis: MLPA

What does this test Nephrogenic Diabetes Insipidus Gene Panel identify?

  • Nephrogenic Diabetes Insipidus Gene Panel identifies genetic mutations in genes associated with nephrogenic diabetes insipidus, a rare condition characterized by the inability of the kidneys to properly concentrate urine.
  • The panel typically includes testing for mutations in genes such as AQP2, AVPR2, and AQP2, which play a role in the regulation of water reabsorption in the kidneys.
  • Identifying mutations in these genes can help confirm a diagnosis of nephrogenic diabetes insipidus and can also provide information about the specific genetic cause of the condition, which can be useful for guiding treatment decisions and family planning.

Why is this test Nephrogenic Diabetes Insipidus Gene Panel taken?

The Nephrogenic Diabetes Insipidus Gene Panel test is taken to identify genetic mutations that may be causing nephrogenic diabetes insipidus (NDI). NDI is a rare condition characterized by the inability of the kidneys to concentrate urine, leading to excessive thirst and urination.

By analyzing specific genes associated with NDI, this test can help diagnose the condition, determine the type of NDI present, and guide treatment decisions. It can also provide valuable information for genetic counseling and family planning.

Overall, the Nephrogenic Diabetes Insipidus Gene Panel test is essential for understanding the underlying genetic causes of NDI and improving patient care and management.

No FAQs available.

Customer Google Rating